Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty
NCT02525133
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
319
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain, Postoperative
Interventions
DRUG:
XaraColl
OTHER:
Placebo
Sponsor
Innocoll